Trial intelligence / Profile preview

Ticagrelor in Microvascular Angina

NCT02284048Phase 4Unknown

Sponsor
The Second Xiangya Hospital
Start
Nov 2014
Primary completion
Nov 2016
Modality
Small Molecules
01

Overview

A Phase 4 trial of ticagrelor in microvascular angina (MVA), sponsored by The Second Xiangya Hospital. Status: unknown.

02

Drugs

ticagrelor
03

Conditions

microvascular angina (MVA)

Beyond the preview

Go deeper on NCT02284048.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02284048.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call